Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
City Therapeutics is a biopharmaceutical company focused on developing next-generation small interfering RNAs.
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
Amount is a digital technology company that accelerates digital transformation for financial institutions.
Neptune Medical is a medical device company that develops endoscopic and surgical devices.
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.
Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites
Mission Lane is a consumer finance company dedicated to helping everyone have access to fair and clear credit.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Adevinta is a digital marketplace that provides online classifieds services.
Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.
HDAI is an health care analytics company with a platform that creates a shared understanding of health risks and personalized care profiles.
Finastra provides the broadest portfolio of financial services software.
Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Presidio Medical is a medtech company that develops a transformational neuromodulation platform.
Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.
Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.
HappyVore cultivates a passion for taste, the real, the healthy, and the impact on the planet.
MOMA Therapeutics operates as a biotechnology company.
Learn In is an upskilling-as-a-service platform that connects employers and learners.
Invus has invested in 108 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Invus's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Information Technology. The firm invests across 39 different industry categories.
Among tracked funding rounds, Finastra received $5.3B in a Debt Financing round. Invus's total known invested capital is $5.5B.
Invus's average investment size is $81.9M across its portfolio of 108 companies.
Recent Invus portfolio additions include City Therapeutics, Convergent Therapeutics, Amount, Neptune Medical, Cartesian Therapeutics. These companies were founded in 2020 or later.